Literature DB >> 29699984

Prevalence of glaucoma in the Australian National Eye Health Survey.

Stuart Keel1, Jing Xie2, Joshua Foreman2,3, Pei Ying Lee2, Mostafa Alwan2, Eamonn T Fahy2, Peter van Wijngaarden2,3, Jennifer C Fan Gaskin2, Ghee Soon Ang2, Jonathan G Crowston2,3, Hugh R Taylor4, Mohamed Dirani2,5.   

Abstract

AIM: To estimate the prevalence of glaucoma in Australia.
METHODS: This was a population-based study of 3098 non-Indigenous Australians (50-98 years) and 1738 Indigenous Australians (40-92 years) stratified by remoteness. Each participant underwent a standard examination that included visual field assessment, tonometry and non-mydriatic fundus photography. Two fellowship-trained glaucoma specialists independently assessed relevant case notes (past ocular history, best-corrected visual acuity, frequency doubling technology visual fields, Van Herick grade, intraocular pressure and optic disc-centred photographs) and assigned a diagnosis ranked on a scale of certainty: none, possible, probable or definite glaucoma.
RESULTS: A total of 4792 (99.1%, 3062 non-Indigenous and 1730 Indigenous) participants had retinal photographs in at least one eye that were gradable for glaucoma. The weighted prevalence of glaucoma (definite) in non-Indigenous Australians and Indigenous Australians was 1.5% (95% CI 1.0 to 2.2) and 0.6% (95% CI 0.4 to 1.1), respectively. When definite and probable cases of glaucoma were combined, rates were 3.4% (95% CI 2.7 to 4.3) among non-Indigenous and 1.6% (95% CI 1.1 to 2.3) in Indigenous Australians. Only 52.4% of non-Indigenous Australians and 28.0% of Indigenous Australians with glaucoma self-reported a known history of glaucoma.
CONCLUSION: We estimate that 198 923 non-Indigenous Australians aged 50 years and over and 2139 Indigenous Australians aged 40 years and over have glaucoma. Given the high rates of undiagnosed glaucoma coupled with a significant ageing of the Australian population, improvements in case detection and access to low vision rehabilitation services may be required to cope with the growing burden of glaucoma. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; glaucoma; public health

Mesh:

Year:  2018        PMID: 29699984     DOI: 10.1136/bjophthalmol-2017-311786

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Exploring the Molecular Mechanism of Qing Guang An Granule in Treating Glaucoma Using Network Pharmacology and Molecular Docking.

Authors:  Chen Ou; Houpan Song; Yasha Zhou; Jun Peng; Qinghua Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-23       Impact factor: 2.629

2.  Online circular contrast perimetry via a web-application: optimising parameters and establishing a normative database.

Authors:  Simon Edward Skalicky; Deus Bigirimana; Lazar Busija
Journal:  Eye (Lond)       Date:  2022-05-16       Impact factor: 4.456

3.  Agreement of Optic Nerve Head Evaluation of Primary Open-Angle Glaucoma Between General Ophthalmologists and Glaucoma Specialists.

Authors:  Xiangmei Kong; Ying Huang; Wenqing Zhu; Mingshui Fu; Xi Shen; Fang Wang; Xinghuai Sun
Journal:  Risk Manag Healthc Policy       Date:  2021-05-06

4.  Vision Impairment Provides New Insight Into Self-Motion Perception.

Authors:  Wilson Luu; Barbara Zangerl; Michael Kalloniatis; Stephen Palmisano; Juno Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-02-01       Impact factor: 4.799

5.  Profile of Glaucoma in the Eastern Region of Saudi Arabia: A Retrospective Study.

Authors:  Halah Bin Helayel; Aysha AlOqab; Majed Al Subaie; Ahmed Al Habash
Journal:  Saudi J Med Med Sci       Date:  2021-04-29

6.  Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017.

Authors:  Yi Sun; Aiming Chen; Minjie Zou; Yichi Zhang; Ling Jin; Yi Li; Danying Zheng; Guangming Jin; Nathan Congdon
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 2.692

7.  Glaucoma Suspects: The Impact of Risk Factor-Driven Review Periods on Clinical Load, Diagnoses, and Healthcare Costs.

Authors:  Jack Phu; Katherine Masselos; Michael Sullivan-Mee; Michael Kalloniatis
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

8.  Prevalence of Eye Conditions, Utilization of Eye Health Care Services, and Ophthalmic Medications After Entering Residential Aged Care in Australia.

Authors:  Jyoti Khadka; Julie Ratcliffe; Gillian E Caughey; Steve L Wesselingh; Maria C Inacio
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

9.  Diabetes mellitus and incident glaucoma in Australia: a 10-year cohort study from the 45 and Up Study.

Authors:  Yu Jiang; Guobei Xiao; Xiaotong Han; Zhuoting Zhu; Xianwen Shang; Ruilin Xiong; Jane Scheetz; Lei Zhang; Katerina V Kiburg; Mingguang He
Journal:  Ann Transl Med       Date:  2022-08

Review 10.  Considerations for Training and Workforce Development to Enhance Rural and Remote Ophthalmology Practise in Australia: A Scoping Review.

Authors:  Kehinde Obamiro; Belinda Jessup; Penny Allen; Victoria Baker-Smith; Santosh Khanal; Tony Barnett
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.